期刊文献+

抵抗素及其启动子-420C/G多态性与肥胖、肥胖伴2型糖尿病的相关性 被引量:2

Association of serum resistin level and its promoter-420C/G polymorphism and obesity and obesity with type 2 diabetes mellitus
下载PDF
导出
摘要 目的探讨抵抗素水平及其基因多态性位点-420C/G与肥胖、肥胖伴2型糖尿病的相关性。方法选择60例正常对照者、67例单纯肥胖患者、63例肥胖伴2型糖尿病患者,测量身高(H)、体重(W),计算体重指数,测定空腹血糖(FPG)、空腹胰岛素(FINS)、抵抗素和总胆固醇(CHO)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白A(ApoA)、载脂蛋白B(ApoB),计算胰岛素抵抗指数(HOMA-IR),检测抵抗素基因-420C/G位点多态性,并对血清抵抗素水平、抵抗素基因-420C/G多态性与肥胖、肥胖伴2型糖尿病的相关性进行分析。结果 1)单纯肥胖组与肥胖伴2型糖尿病组抵抗素和FINS均高于正常对照组(P值均<0.05);单纯肥胖组与肥胖伴2型糖尿病组的抵抗素和FINS比较,差异均无统计学意义(P>0.05);HOMA-IR 3组间两两比较,差异均有统计学意义(P值均<0.05)。2)抵抗素基因-420C/G位点G等位基因频率3组间两两比较,差异均无统计学意义(P>0.05)。结论单纯肥胖者及肥胖伴2型糖尿病者血清抵抗素水平显著升高,与HOMA-IR呈正相关,抵抗素可能参与胰岛素抵抗的发生,但与胰岛素抵抗的发展及与肥胖至2型糖尿病的发病过程的关系尚待证实。抵抗素-420C/G位点G等位基因频率与胰岛素抵抗的发生无显著相关。 Objective To assess the association between-420C/G variant of resistin gene, plasma resistin, and obesity, and obesity with type 2 diabetes mellitus. Methods We selected 60 cases of control, 67 cases of obesity, and 63 cases of obesi- ty with diabetes. Their height (H), weight (W), fasting plasma glucose (FPG), fasting insulin (FINS), fasting plasma re- sistin, total cholesterol (CHO), triglycerides (TG), high density lipoprotein-cholesterol (HDL-C), low density lipoprbtein- cholesterol (LDL-C), apolipoprotein A (ApoA) and apolipoprotein B (ApoB) were measured. Insulin resistance index was used to analyse the relation between resistin and insulin resistance. The association between promoter-420C/G variant of resistin gene, plasma resistin, and obesity, and insulin resistance were assessed. Results 1) Resistin, FINS, Homa-IR in obesity group and obesity with diabetes group were significantly higher than those in control group (all P^0.05). And there was no difference in obesity and obesity with diabetes group except Homa-IR. 2) There was no significant difference of GG, CC and G/ C alleles frequencies between three groups. Conclusion The level of fasting plasma resistin increases in patients with obesity. The correlation between Homa-IR and resistin suggests that resistin is involved in insulin resistance. The allele G of-420C/G polymorphism is uncorrelated with insulin resistance.
出处 《福建医药杂志》 CAS 2013年第4期1-3,49,共4页 Fujian Medical Journal
基金 福建省教育厅B类科技项目(JB10231)
关键词 抵抗素 基因多态性 肥胖 胰岛素抵抗 resistin gene polymorphism BMI insulin resistance
  • 相关文献

参考文献7

二级参考文献29

共引文献7

同被引文献22

  • 1李秀珍,刘丽,赵小媛,吴冬燕,程静,卢惠珍.肥胖儿童血清抵抗素变化及其临床意义[J].临床儿科杂志,2005,23(8):507-509. 被引量:11
  • 2甘华侠,徐积兄,刘建英,罗旭敏,李雯霞,朱凌燕,程捷.糖耐量减低者血清抵抗素与肥胖的相关性研究[J].实用临床医学(江西),2007,8(6):19-22. 被引量:2
  • 3Steppan CM, Bailey ST, Bhat S, et al.The hormone resistin links obesity to diabetes. Nature.2001,409(6818):307-312.
  • 4Schwartz DR, Lazar MA.Human resistin: found in translation from mouse to man. Trends Endocrinol Metab.2011,22(7):259-265.
  • 5FAQ S.How can I compare regression coefficients across three (or more) groups?.UCLA: Statistical Consulting Group From http://wwwatsuclaedu/stat/sas/faq/compreg3htm.
  • 6Rajala MW, Qi Y, Patel HR, et al.Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes.2004,53(7): 1671-1679.
  • 7Fain JN, Cheema PS, Bahouth SW, et al.Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun.2003,300(3):674-678.
  • 8Patel L, Buckels AC, Kinghorn I J, et al.Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun.2003,300(2):472-476.
  • 9Savage DB, Sewter CP, Klenk ES, et al.Resistin /Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes.2001,50(10):2199-2202.
  • 10Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, et al.Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab. 2003,88(11):5452-5455.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部